MXPA03000650A - Compuesto farmaceuticamente activo. - Google Patents

Compuesto farmaceuticamente activo.

Info

Publication number
MXPA03000650A
MXPA03000650A MXPA03000650A MXPA03000650A MXPA03000650A MX PA03000650 A MXPA03000650 A MX PA03000650A MX PA03000650 A MXPA03000650 A MX PA03000650A MX PA03000650 A MXPA03000650 A MX PA03000650A MX PA03000650 A MXPA03000650 A MX PA03000650A
Authority
MX
Mexico
Prior art keywords
active compound
pharmaceutically active
pharmaceutically
compound
active
Prior art date
Application number
MXPA03000650A
Other languages
English (en)
Inventor
Charles Oswald Mills
Original Assignee
Norgine Europe Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norgine Europe Bv filed Critical Norgine Europe Bv
Publication of MXPA03000650A publication Critical patent/MXPA03000650A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/554Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA03000650A 2000-07-21 2001-07-19 Compuesto farmaceuticamente activo. MXPA03000650A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0017822.8A GB0017822D0 (en) 2000-07-21 2000-07-21 Pharmaceutically active compound
PCT/GB2001/003232 WO2002007771A1 (en) 2000-07-21 2001-07-19 Pharmaceutically active compound

Publications (1)

Publication Number Publication Date
MXPA03000650A true MXPA03000650A (es) 2003-06-06

Family

ID=9896025

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03000650A MXPA03000650A (es) 2000-07-21 2001-07-19 Compuesto farmaceuticamente activo.

Country Status (10)

Country Link
US (2) US20040053896A1 (es)
EP (1) EP1301212A1 (es)
JP (1) JP2004504359A (es)
KR (1) KR20030024800A (es)
CN (1) CN1452498A (es)
AU (1) AU2001270865A1 (es)
CA (1) CA2416608A1 (es)
GB (1) GB0017822D0 (es)
MX (1) MXPA03000650A (es)
WO (1) WO2002007771A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050066459A1 (en) * 2003-09-09 2005-03-31 The Procter & Gamble Company Electric toothbrushes and replaceable components
CN107686498B (zh) * 2016-08-05 2020-11-27 首都医科大学 阿霉素-胆酸缀合物,其合成,活性和应用
CN110804082B (zh) * 2019-11-25 2020-11-17 中国医学科学院医药生物技术研究所 一种胆酸类衍生物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220598A (en) * 1977-11-14 1980-09-02 Abbott Laboratories Method and reagents for measuring the level of conjugated bile acids
JPS62175497A (ja) * 1986-01-28 1987-08-01 Wakunaga Pharmaceut Co Ltd 胆汁酸誘導体およびその製造法
IT1283182B1 (it) * 1996-03-04 1998-04-16 Prodotti Chimici Alimentari Composti coniugati di acidi biliari con tio-taurina e suoi n-alchilderivati
GB9716962D0 (en) * 1997-08-12 1997-10-15 Univ Birmingham Liver function test

Also Published As

Publication number Publication date
KR20030024800A (ko) 2003-03-26
US20050239712A1 (en) 2005-10-27
GB0017822D0 (en) 2000-09-06
CN1452498A (zh) 2003-10-29
JP2004504359A (ja) 2004-02-12
AU2001270865A1 (en) 2002-02-05
WO2002007771A1 (en) 2002-01-31
CA2416608A1 (en) 2002-01-31
EP1301212A1 (en) 2003-04-16
US20040053896A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
HK1050367A1 (en) Pharmaceutically active compounds.
GB9924020D0 (en) Pharmaceutically active compounds
IL146117A0 (en) New pharmaceutically active compounds
GB9823101D0 (en) Pharmaceutically active compounds
HK1037453A1 (en) Earphone.
AP2000001869A0 (en) Pharmaceutically active morpholinol
HK1048306A1 (en) Pharmaceutically active sulfonamide derivatives.
ZA200006352B (en) Compound napkin.
IL140974A0 (en) Active prompts
ZA200200106B (en) Orally active androgens.
GB9823102D0 (en) Pharmaceutically active compounds
GB0105893D0 (en) Pharmaceutically active compounds
GB0107751D0 (en) Pharmaceutically active compounds
GB0106631D0 (en) Pharmaceutically active compounds
AU6036100A (en) New pharmaceutically active compounds
MXPA03000650A (es) Compuesto farmaceuticamente activo.
HK1055954A1 (en) Crystalline therapeutic agent.
GB0018656D0 (en) Pharmaceutically active compounds
GB0018660D0 (en) Pharmaceutically active compounds
GB0007345D0 (en) Pharmaceutically active compounds
GB9926630D0 (en) Pharmacologically active compounds
GB0219897D0 (en) Pharmaceutically active compounds
GB0106629D0 (en) Pharmaceutically active compounds
GB0106651D0 (en) Pharmaceutically active compounds
GB0106561D0 (en) Pharmaceutically active compounds